Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients
Glauce C. U. Tostes Maria Elizabeth R Silva; Rosa Tsunechiro Fukui; Dalva Marreiro Rocha; Bernardo Leo Wajchenberg; ENDO 06 - Annual Meeting the endocrine society's (88. 2006 Boston)
Resumos Boston p. 319, res. P1-620, 2006Boston 2006
Localização: FM - Fac. Medicina (FM BCSEP 245 2006 ) e outros locais(Acessar)